In findings that may eventually change the way breast cancer is evaluated and treated, a new study reports that the BluePrint genomic test provides more accurate information about the molecular subtype of a specific breast cancer, compared to the use of conventional IHC-FISH pathology tests.

The Wagner-Torizuka fellowship, created by Henry N. Wagner, Jr., MD, and Kanji Torizuka, MD, PhD, provides Japanese clinicians in the field of molecular imaging a major platform for advanced training and research. Three physicians have been honored with the fellowship, SNMMI announced yesterday. 

A targeted molecular imaging technique could aid in the prevention of blindness associated with progressive diabetic neuropathy by tracking alterations in the retinal endothelium, the Federation of American Societies for Experimental Biology (FASEB) announced yesterday.

The amyloid PET radiotracer F-18 flutemetamol (Vizamyl) has been given the CE mark from the European Commission authorizing marketing of the drug across Europe, GE Healthcare announced yesterday.

In the world of cancer screening, there may be a bias of accessibility that is skewed toward more screening when doctors are paid more by Medicaid, according to a study conducted by the division of health services and social policy research at RTI International in Washington, D.C.

Three major quantitative softwares offer cardiologists a comprehensive map of myocardial perfusion and function, but they do not always agree, according to a study in the August issue of the Journal of Nuclear Cardiology.

F-18 Flutemetamol (F-18 Flute) alone has been used to procure positive or negative results in visual interpretations of beta-amyloid in the brain as a tool to aid in the diagnosis and study of Alzheimer’s disease. Quantitative analysis could further supercharge this technique by bringing in more data about regional and total tracer uptake, according to a study published Aug. 21 in the Journal of Nuclear Medicine.

Radiant Sage LLC, a provider of on-demand clinical trial imaging infrastructure solutions, today announced that it has been named to CIOReview's list of 100 Most Promising Technology Companies. The CIOReview100 includes companies that are gaining momentum in the technology industry and making an impact.